These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38312738)

  • 1. Prescription drug spending by payer: Implications for managed care.
    Chavehpour Y; Balkrishnan R; Segel JE
    Explor Res Clin Soc Pharm; 2024 Mar; 13():100406. PubMed ID: 38312738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019.
    Clemans-Cope L; Epstein M; Banthin J; Kesselheim AS; Hwang TJ
    JAMA Health Forum; 2023 Jan; 4(1):e225012. PubMed ID: 36637815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of U.S. federal and state generic drug policies on drug use, spending, and patient outcomes: A systematic review.
    Mishuk AU; Fasina I; Qian J
    Res Social Adm Pharm; 2020 Jun; 16(6):736-745. PubMed ID: 31445986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
    Hwang TJ; Jain N; Lauffenburger JC; Vokinger KN; Kesselheim AS
    JAMA Intern Med; 2019 Mar; 179(3):374-380. PubMed ID: 30640379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Added Therapeutic Benefit of Top-Selling Brand-name Drugs in Medicare.
    Egilman AC; Rome BN; Kesselheim AS
    JAMA; 2023 Apr; 329(15):1283-1289. PubMed ID: 37071095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price Trends.
    Atzinger CB; Guo JJ
    Am Health Drug Benefits; 2017 Feb; 10(1):27-36. PubMed ID: 28465766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Prices of Popular Brand-Name Prescription Drugs in the United States.
    Wineinger NE; Zhang Y; Topol EJ
    JAMA Netw Open; 2019 May; 2(5):e194791. PubMed ID: 31150077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
    LaVange LM; Silverman HA
    Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018.
    Lin SY; Baumann K; Zhou C; Zhou W; Cuellar AE; Xue H
    JAMA Netw Open; 2021 Nov; 4(11):e2135371. PubMed ID: 34807258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies.
    Carroll NV
    J Manag Care Spec Pharm; 2014 Sep; 20(9):959-67. PubMed ID: 25166295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophthalmic Medication Expenditures and Out-of-Pocket Spending: An Analysis of United States Prescriptions from 2007 through 2016.
    Chen EM; Kombo N; Teng CC; Mruthyunjaya P; Nwanyanwu K; Parikh R
    Ophthalmology; 2020 Oct; 127(10):1292-1302. PubMed ID: 32359935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Out-of-Pocket Costs for and Characteristics of Pharmacy-Dispensed Buprenorphine Medications for Opioid Use Disorder Treatment by Type of Payer, 2015 to 2020.
    Strahan AE; Desai S; Zhang K; Guy GP
    JAMA Netw Open; 2023 Feb; 6(2):e2254590. PubMed ID: 36763363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaining Coverage Through Medicaid Or Private Insurance Increased Prescription Use And Lowered Out-Of-Pocket Spending.
    Mulcahy AW; Eibner C; Finegold K
    Health Aff (Millwood); 2016 Sep; 35(9):1725-33. PubMed ID: 27534776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US Health Care Spending by Payer and Health Condition, 1996-2016.
    Dieleman JL; Cao J; Chapin A; Chen C; Li Z; Liu A; Horst C; Kaldjian A; Matyasz T; Scott KW; Bui AL; Campbell M; Duber HC; Dunn AC; Flaxman AD; Fitzmaurice C; Naghavi M; Sadat N; Shieh P; Squires E; Yeung K; Murray CJL
    JAMA; 2020 Mar; 323(9):863-884. PubMed ID: 32125402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing patient OOP spending for specialty drugs in Medicare Part D and employer-sponsored insurance.
    Parasrampuria S; Sen AP; Anderson GF
    Am J Manag Care; 2020 Sep; 26(9):388-394. PubMed ID: 32930551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs.
    Rome BN; Feldman WB; Desai RJ; Kesselheim AS
    JAMA Netw Open; 2021 May; 4(5):e218816. PubMed ID: 33944925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographical Variation in Health Spending Across the US Among Privately Insured Individuals and Enrollees in Medicaid and Medicare.
    Cooper Z; Stiegman O; Ndumele CD; Staiger B; Skinner J
    JAMA Netw Open; 2022 Jul; 5(7):e2222138. PubMed ID: 35857326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional Variation in Physician Adoption of Antipsychotics: Impact on US Medicare Expenditures.
    Donohue JM; Normand SL; Horvitz-Lennon M; Men A; Berndt ER; Huskamp HA
    J Ment Health Policy Econ; 2016 Jun; 19(2):69-78. PubMed ID: 27453458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Expenditure, Price, and Utilization in the U.S. Medicaid: A Trend Analysis for SSRI and SNRI Antidepressants from 1991 to 2018.
    Alrasheed M; Hincapie AL; Guo JJ
    J Ment Health Policy Econ; 2021 Mar; 24(1):3-11. PubMed ID: 33739932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.